Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)-Reference-Cited by-同舟云学术

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Published:2007-01-24 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Miller Robert G,Mitchell J D,Lyon Mary,Moore Dan H

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001447.pub2/epdf/full

Reference41 articles.

1. A controlled trial of riluzole in amyotrophic lateral sclerosis. The ALS/Riluzole Study Group;Bensimon;New England Journal of Medicine,1994

2. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis;Bensimon;Journal of Neurology,2002

3. Meininger V Lacomblez L Bensimon G Unpublished report: controlled trial of riluzole in patients with advanced ALS RP 54272-302 1995

4. Dose-ranging study of riluzole in amyotrophic lateral sclerosis;Lacomblez;Lancet,1996

5. Efficacy and safety of riluzole in patients with amyotrophic lateral sclerosis: double-blind placebo-controlled study in Japan;Yanagisawa;Igakuno Ayumi,1997

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in microRNA profiling of circulating extracellular vesicles in amyotrophic lateral sclerosis: A systematic review;Neurobiology of Disease;2024-10

2. Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression;Current Pharmaceutical Design;2024-09

3. Effect of ultrasound-mediated blood-spinal cord barrier opening on survival and motor function in females in an amyotrophic lateral sclerosis mouse model;eBioMedicine;2024-08

4. Role of pharmacotherapy in the treatment of amyotrophic lateral sclerosis;Klinická farmakologie a farmacie;2024-07-15

5. A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial;PLOS ONE;2024-07-11